FINANCIAL CASE

Home/ Service/
CBD Oil

Special TIME for INVESTMENT

Ventura will show how a well-run, well-regulated, highly professional Plant
Breeding Company can be a significant and a positive contributor and help the
new industry thrive.

 

Contact us for more information

Medical Cannabis Market

The global legal cannabis market is valued at $17.7 billion3 in 2019, growing by about 22 percent,  according to the report from Grand ViewResearch.

Spending on legal cannabis worldwide is expected to reach $42.7 billion by 2024 at a compound annual  growth rate (CAGR) of 25% from 2019 and hit $57 billion by 2027, while the cannabis market in the  United States and Canada is estimated to be about $46.5 billion and another $10.5 billion for other  markets. The largest growth rate is predicted within the rest-of-world markets with projected $2.5  billion in2027.

Legal medical cannabis spending outside the U.S. and Canada more than doubled in 2019, from $367  million to $840 million, largely due to markets in Germany and Mexico. According to the report, the  global medical cannabis market is projected to increase in value to $14.09 billion in 2024 at a CAGR of  10% from 2019 to2024.

Key Trends:

  • The initial decision by many U.S. states and Canada to create medical-only cannabis regulations prompted many other countries to act similarly while legalization of adult recreational use in California and Canada triggered a second wave of legalizing laws internationally to increase  access to medical cannabis.
  • South American countries have the most liberal medical cannabis programs. Led by Brazil, Argentina, Peru and Uruguay, the South American medical cannabis market may grow from $125 million in 2018 to $776 million in 2027.
  • Germany is ready to become the leader of the European cannabis market, and Italy is expected to be second with $1.2 billion in sales by 2027. Some form of medical cannabis is now legal in 22 countries in Europe.
  • Australia’s legal cannabis market is forecast to grow from $52 million in 2018 to $1.2 billion in 2027, the 5th largest in the world.
  • Israel has a small population and a long history of legal medical cannabis use. It continues to be a leader over the years in the development of cannabis pharmaceuticals.

GREENHOUSE CULTIVATIONFACILITY

  • 4 High-tech Greenhouses of 762 square meters
  • Cultivation and Breeding
  • Research & Innovationlab
  • 600 m2 of vacant area to expand facility

PHYTOTRON FACILITY

  • 4 High-tech Greenhouses of 762 square meters
  • Cultivation and Breeding
  • Research & Innovationlab
  • 600 m2 of vacant area to expand facility

OFFICE ASSOCIATED BUILDINGS

  • 3 Associated Service Buildings
  • 450m2
  • Reception & Offices for GMP & GACP
  • Currently in use

Certified Quality

We pruduce premium craft cannabis and test new clones in large scale. Harvest cycle every 7 days.

Organic Medicine

We develop new exclusive GMO-free strains to become a major supplier of clones to licensed high-end producers.